MENU

APGE Stock Tickeron detected bullish Stock Pattern: Broadening Top APGE on September 20, 2024, netting in a 13.16% gain over 5 days

A.I.dvisor
at Tickeron.com
09/26/24
Loading...
+13.16% Gain from a Successful pattern Broadening Top
APGE - Apogee Therapeutics
Tickeron
Ticker: APGE
Company: Apogee Therapeutics
Gain: +13.16%
Confirmed: 09/20/24
Succeeded: 09/24/24
Total length: 5 days
On September 19, 2024, A.I.dvisor detected a Broadening Top Pattern (Bullish) for Apogee Therapeutics (APGE, $52.95). On September 20, 2024, A.I.dvisor confirmed the Bullish pattern, setting a target price of $58.95. 4 days later, on September 24, 2024, APGE reached the target price resulting in a +1 for traders who took a long position in the stock.

APGE in upward trend: price rose above 50-day moving average on November 01, 2024

APGE moved above its 50-day moving average on November 01, 2024 date and that indicates a change from a downward trend to an upward trend. In of 3 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 12 cases where APGE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 01, 2024. You may want to consider a long position or call options on APGE as a result. In of 15 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for APGE just turned positive on November 04, 2024. Looking at past instances where APGE's MACD turned positive, the stock continued to rise in of 10 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where APGE advanced for three days, in of 81 cases, the price rose further within the following month. The odds of a continued upward trend are .

APGE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where APGE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for APGE entered a downward trend on November 04, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. APGE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.992) is normal, around the industry mean (14.125). P/E Ratio (0.000) is within average values for comparable stocks, (131.373). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.394). APGE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (235.543).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APGE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
APGE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
221 Crescent Street
Phone
+1 650 394-5230
Employees
91
Web
https://www.apogeetherapeutics.com